Abstract

The trimeric HIV-1 Envelope protein (Env) mediates viral-host cell fusion via a network of conformational transitions, with allosteric elements in each protomer orchestrating host receptor-induced exposure of the co-receptor binding site and fusion elements. To understand the molecular details of this allostery, here, we introduce Env mutations aimed to prevent CD4-induced rearrangements in the HIV-1 BG505 Env trimer. Binding analysis and single−molecule Förster Resonance Energy Transfer confirm that these mutations prevent CD4-induced transitions of the HIV-1 Env. Structural analysis by single−particle cryo-electron microscopy performed on the BG505 SOSIP mutant Env proteins shows rearrangements in the gp120 topological layer contacts with gp41. Displacement of a conserved tryptophan (W571) from its typical pocket in these Env mutants renders the Env insensitive to CD4 binding. These results reveal the critical function of W571 as a conformational switch in Env allostery and receptor-mediated viral entry and provide insights on Env conformation that are relevant for vaccine design.

Here, using cryo-EM and smFRET, Henderson et al. show how tryptophan 571 in the HIV-1 Env acts as a conformational switch during receptor-mediated viral entry and design HIV-1 Env proteins that cannot undergo conformational changes. This has important implications for HIV-1 vaccine design.

Details

Title
Disruption of the HIV-1 Envelope allosteric network blocks CD4-induced rearrangements
Author
Henderson, Rory 1   VIAFID ORCID Logo  ; Lu, Maolin 2 ; Zhou, Ye 3 ; Mu Zekun 4   VIAFID ORCID Logo  ; Parks, Robert 5 ; Han, Qifeng 1   VIAFID ORCID Logo  ; Hsu, Allen L 6   VIAFID ORCID Logo  ; Carter, Elizabeth 1 ; Blanchard, Scott C 7   VIAFID ORCID Logo  ; Edwards, R J 1 ; Wiehe, Kevin 1 ; Saunders, Kevin O 8   VIAFID ORCID Logo  ; Borgnia, Mario J 6 ; Bartesaghi, Alberto 9 ; Mothes Walther 2 ; Haynes, Barton F 10 ; Acharya Priyamvada 8 ; Munir, Alam S 11 

 Duke University School of Medicine, Department of Medicine, Durham, USA (GRID:grid.26009.3d) (ISNI:0000 0004 1936 7961); Duke University School of Medicine, Duke Human Vaccine Institute, Durham, USA (GRID:grid.26009.3d) (ISNI:0000 0004 1936 7961) 
 Yale University School of Medicine, Department of Microbial Pathogenesis, New Haven, USA (GRID:grid.47100.32) (ISNI:0000000419368710) 
 Duke University, Department of Computer Science, Durham, USA (GRID:grid.26009.3d) (ISNI:0000 0004 1936 7961) 
 Duke University School of Medicine, Department of Immunology, Durham, USA (GRID:grid.26009.3d) (ISNI:0000 0004 1936 7961) 
 Duke University School of Medicine, Duke Human Vaccine Institute, Durham, USA (GRID:grid.26009.3d) (ISNI:0000 0004 1936 7961) 
 Department of Health and Human Services, Genome Integrity and Structural Biology Laboratory, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, USA (GRID:grid.26009.3d) 
 Weill Cornell Medicine, Department of Physiology and Biophysics, New York, USA (GRID:grid.5386.8) (ISNI:000000041936877X); Department of Structural Biology, St. Jude Children’s Research Hospital, Memphis, USA (GRID:grid.5386.8) 
 Duke University School of Medicine, Duke Human Vaccine Institute, Durham, USA (GRID:grid.26009.3d) (ISNI:0000 0004 1936 7961); Duke University School of Medicine, Department of Surgery, Durham, USA (GRID:grid.26009.3d) (ISNI:0000 0004 1936 7961) 
 Duke University, Department of Computer Science, Durham, USA (GRID:grid.26009.3d) (ISNI:0000 0004 1936 7961); Duke University School of Medicine, Department of Biochemistry, Durham, USA (GRID:grid.26009.3d) (ISNI:0000 0004 1936 7961); Duke University, Department of Electrical and Computer Engineering, Durham, USA (GRID:grid.26009.3d) (ISNI:0000 0004 1936 7961) 
10  Duke University School of Medicine, Department of Medicine, Durham, USA (GRID:grid.26009.3d) (ISNI:0000 0004 1936 7961); Duke University School of Medicine, Duke Human Vaccine Institute, Durham, USA (GRID:grid.26009.3d) (ISNI:0000 0004 1936 7961); Duke University School of Medicine, Department of Immunology, Durham, USA (GRID:grid.26009.3d) (ISNI:0000 0004 1936 7961) 
11  Duke University School of Medicine, Department of Medicine, Durham, USA (GRID:grid.26009.3d) (ISNI:0000 0004 1936 7961); Duke University School of Medicine, Duke Human Vaccine Institute, Durham, USA (GRID:grid.26009.3d) (ISNI:0000 0004 1936 7961); Duke University School of Medicine, Department of Pathology, Durham, USA (GRID:grid.26009.3d) (ISNI:0000 0004 1936 7961) 
Publication year
2020
Publication date
2020
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2344544532
Copyright
This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.